Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request, 72188-72190 [2014-28555]
Download as PDF
<![CDATA[
72188
Federal Register / Vol. 79, No. 234 / Friday, December 5, 2014 / Notices
TABLE 1—Continued
Application No.
Drug
Applicant
Do.
Teva Pharmaceuticals USA.
Do.
Do.
Alkermes Gainesville LLC, 1300 Gould Dr., Gainesville, GA
30504.
Mylan Pharmaceuticals, Inc.
Do.
Do.
Do.
ANDA
ANDA
ANDA
ANDA
ANDA
074126
074589
074828
074849
074879
....
....
....
....
....
Atenolol Tablets USP, 25 mg, 50 mg, and 100 mg ................
Minoxidil Topical Solution, 2% .................................................
Acyclovir Capsules, 200 mg ....................................................
Clomipramine HCl Capsules, 25 mg, 50 mg, and 75 mg .......
Ketoprofen Extended-Release Capsules, 200 mg ..................
ANDA
ANDA
ANDA
ANDA
074976
074977
075161
075472
....
....
....
....
Acyclovir Tablets USP, 400 mg and 800 mg ..........................
Acyclovir Capsules USP, 200 mg ............................................
Ticlopidine HCl Tablets USP, 250 mg .....................................
Enalapril Maleate Tablets USP, 2.5 mg, 5 mg, 10 mg, and 20
mg.
Nizatidine Capsules USP, 150 mg and 300 mg ......................
Quinapril Tablets USP, 5 mg, 10 mg, 20 mg, and 40 mg .......
Metoprolol Succinate Extended-Release Tablets USP, 25
mg, 50 mg, 100 mg, and 200 mg.
Terbinafine HCl Tablets, 250 mg .............................................
Sumatriptan Succinate Tablets, 25 mg, 50 mg, and 100 mg ..
Divalproex Sodium Delayed-Release Tablets USP, 125 mg,
250 mg, and 500 mg.
Glimepiride Tablets USP, 1 mg, 2 mg, and 4 mg ...................
Fosinopril Sodium and Hydrochlorothiazide Tablets, 10 mg/
12.5 mg and 20 mg/12.5 mg.
Meloxicam Tablets USP, 7.5 mg and 15 mg ...........................
Cromolyn Sodium Nasal Solution USP, 5.2 mg/1 spray .........
ANDA 075934 ....
ANDA 076036 ....
ANDA 076969 ....
ANDA 077136 ....
ANDA 077163 ....
ANDA 077254 ....
ANDA 077486 ....
ANDA 077705 ....
ANDA 077934 ....
ANDA 077976 ....
ANDA 078638 ....
ANDA 078731 ....
ANDA
ANDA
ANDA
ANDA
ANDA
079184
081295
084499
084500
085794
....
....
....
....
....
ANDA 085795 ....
ANDA 087176 ....
ANDA 087653 ....
ANDA 088833 ....
ANDA 088896 ....
NDA 202343 ......
Alendronate Sodium Tablets USP, 35 mg and 70 mg ............
Levetiracetam Tablets, 250 mg, 500 mg, 750 mg, and 1,000
mg.
Ursodiol Tablets USP, 250 mg and 500 mg ............................
Estradiol Tablets USP, 0.5 mg ................................................
Estradiol Tablets USP, 1 mg ...................................................
Estradiol Tablets USP, 2 mg ...................................................
Acetaminophen and Codeine Phosphate Tablets USP, 300
mg/30 mg.
Acetaminophen and Codeine Phosphate Tablets USP, 300
mg/15 mg.
Chlorthalidone Tablets USP, 50 mg ........................................
Acetaminophen and Codeine Phosphate Tablets USP, 300
mg/60 mg.
Triprolidine HCl, pseudoephedrine HCl, and Codeine Phosphate Cough Syrup, 1.25 mg/5 mL, 30 mg/5 mL, and 10
mg/5 mL.
Promethazine VC with Codeine (promethazine HCl, phenylephrine HCl, and codeine phosphate) Cough Syrup, 6.25
mg/5 mL, 5 mg/5 mL, and 10 mg/5 mL.
Juvisync (sitagliptin and simvastatin) Tablets, 100 mg/10 mg,
100 mg/20 mg, and 100 mg/40 mg.
Do.
Do.
Sandoz, Inc.
Mylan Pharmaceuticals, Inc.
Do.
Do.
Do.
Do.
Do.
HH & P LLC, c/o Kuker Regulatory Consulting, LLC, 18 Dunbar Way, Mahtomedi, MN 55115.
Mylan Pharmaceuticals, Inc.
Do.
Teva Pharmaceuticals USA.
Bristol-Myers Squibb Co.
Do.
Do.
Mutual Pharmaceutical Co., Inc., 1100 Orthodox St., Philadelphia, PA 19124.
Do.
Ivax Pharmaceuticals, Inc., Subsidiary of Teva Pharmaceuticals USA, 400 Chestnut Ridge Rd., Woodcliff Lake,
NJ 07677.
Mutual Pharmaceutical Co., Inc.
Wockhardt Bio AG, c/o Morton Grove Pharmaceuticals, Inc.,
6451 Main St., Morton Grove, IL 60053.
Do.
Merck Sharp & Dohme Corp., 351 North Sumneytown Pike,
P.O. Box 1000, UG2CD–015, North Wales, PA 19454.
wreier-aviles on DSK5TPTVN1PROD with NOTICES
1 This product included an oral pressurized metered-dose inhaler that contained chlorofluorocarbons (CFCs) as a propellant. CFCs may no
longer be used as a propellant for any flunisolide metered-dose inhalers (see 75 FR 19213, April 14, 2010).
Therefore, under section 505(e) of the
Federal Food, Drug, and Cosmetic Act
(the FD&C Act) (21 U.S.C. 355(e)) and
under authority delegated to the
Director, Center for Drug Evaluation and
Research, by the Commissioner,
approval of the applications listed in
table 1 in this document, and all
amendments and supplements thereto,
is hereby withdrawn, effective January
5, 2015. Introduction or delivery for
introduction into interstate commerce of
products without approved new drug
applications violates section 301(a) and
(d) of the FD&C Act (21 U.S.C. 331(a)
and (d)). Drug products that are listed in
VerDate Sep<11>2014
15:07 Dec 04, 2014
Jkt 235001
Table 1 that are in inventory on the date
that this notice becomes effective (see
the DATES section) may continue to be
dispensed until the inventories have
been depleted or the drug products have
reached their expiration dates or
otherwise become violative, whichever
occurs first.
Dated: December 1, 2014.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2014–28541 Filed 12–4–14; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Submission to OMB for
Review and Approval; Public Comment
Request
Health Resources and Services
Administration, HHS.
ACTION: Notice.
AGENCY:
BILLING CODE 4164–01–P
PO 00000
In compliance with Section
3507(a)(1)(D) of the Paperwork
SUMMARY:
Frm 00025
Fmt 4703
Sfmt 4703
E:\FR\FM\05DEN1.SGM
05DEN1
72189
Federal Register / Vol. 79, No. 234 / Friday, December 5, 2014 / Notices
Reduction Act of 1995, the Health
Resources and Services Administration
(HRSA) has submitted an Information
Collection Request (ICR) to the Office of
Management and Budget (OMB) for
review and approval. Comments
submitted during the first public review
of this ICR will be provided to OMB.
OMB will accept further comments from
the public during the review and
approval period.
DATES: Comments on this ICR should be
received no later than January 5, 2015.
ADDRESSES: Submit your comments,
including the Information Collection
Request Title, to the desk officer for
HRSA, either by email to OIRA_
submission@omb.eop.gov or by fax to
202–395–5806.
FOR FURTHER INFORMATION CONTACT: To
request a copy of the clearance requests
submitted to OMB for review, email the
HRSA Information Collection Clearance
Officer at paperwork@hrsa.gov or call
(301) 443–1984.
SUPPLEMENTARY INFORMATION:
Information Collection Request Title:
Health Professions Student Loan (HPSL)
Program and Nursing Student Loan
(NSL) Program Administrative
Requirements (Regulations and Policy).
OMB No. 0915–0047—Extension.
Abstract: The statutory authorities for
the Health Professions Student Loan
(HPSL) Program, as authorized by
Public Health Service (PHS) Act
sections 721–722, and 725–735, and the
Nursing Student Loan (NSL) Program, as
authorized by PHS Act sections 835–
842, contain a number of recordkeeping
and reporting requirements for
academic institutions and loan
applicants. The applicable regulations
for these programs under 42 CFR part 57
details the various requirements (see
chart below).
Need and Proposed Use of the
Information: The requirements are
essential for assuring that borrowers are
aware of their rights and
responsibilities, academic institutions
have accurate records of the history and
status of each loan account in order to
pursue aggressive collection efforts to
reduce default rates, and that academic
institutions maintain adequate records
for audit and assessment purposes to
help the U.S. Department of Health and
Human Services safeguard federal funds
made through the Federal Capital
Contribution (FCC). Academic
institutions are free to use improved
information technology to manage the
information required by the regulations.
Likely Respondents: Financial Aid
Directors working at institutions
participating in the HPSL and NSL
Programs.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose or provide the information
requested. This includes the time
needed to review instructions; to
develop, acquire, install and utilize
technology and systems for the purpose
of collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.
TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS
RECORDKEEPING REQUIREMENTS
Number of
record keepers
Hours per year
HPSL Program:
57.206(b)(2), Documentation of Cost of Attendance ...........................................................
57.208(a), Promissory Note .................................................................................................
57.210((b)(1)(i), Documentation of Entrance Interview ........................................................
57.210(b)(1)(ii), Documentation of Exit Interview .................................................................
57.215(a)&(d), Program Records .........................................................................................
57.215(b), Student Records .................................................................................................
57.215(c), Repayment Records ...........................................................................................
50
90
40
80
140
70
150
325
325
325
334
334
334
334
16,250
29,250
13,000
26,720
46,760
23,380
50,100
HPSL Subtotal ...............................................................................................................
........................
........................
205,460
NSL Program:
57.306(b)(2)(ii), Documentation of Cost of Attendance .......................................................
57.308(a), Promissory Note .................................................................................................
57.310(b)(1)(i), Documentation of Entrance Interview .........................................................
57.310(b)(1)(ii), Documentation of Exit Interview .................................................................
57.315(a)(1)&(a)(4), Program Records ................................................................................
57.315(a)(2), Student Records .............................................................................................
57.315(a)(3), Repayment Records .......................................................................................
16.0
4.5
1.5
1.5
21.0
8.5
5.0
282
282
282
348
348
348
348
4,512
1,269
423
522
7,308
2,958
1,740
NSL Subtotal .................................................................................................................
........................
........................
18,732
Regulatory/section requirements
Total burden
hours
* Includes active and closing schools.
HPSL data includes active and closing Loans for Disadvantaged Students (LDS) program schools.
wreier-aviles on DSK5TPTVN1PROD with NOTICES
REPORTING REQUIREMENTS
Number of
respondents
Regulatory/section requirements
HPSL Program:
57.206(a)(2), Student Financial Aid Transcript ............
57.208(c), Loan Information Disclosure .......................
57.210(b)(1)(i), Entrance Interview ...............................
57.210(b)(1)(ii), Exit Interview ......................................
VerDate Sep<11>2014
15:07 Dec 04, 2014
Jkt 235001
PO 00000
Frm 00026
n/a
325
325
334
Fmt 4703
Responses
per
respondent
Total annual
responses
Hours per
response
Total hour
burden
........................
299.5
139.5
113.5
........................
97,338
45,338
37,909
........................
0.63
0.50
1.00
........................
60,836
22,669
37,909
Sfmt 4703
E:\FR\FM\05DEN1.SGM
05DEN1
72190
Federal Register / Vol. 79, No. 234 / Friday, December 5, 2014 / Notices
REPORTING REQUIREMENTS—Continued
Number of
respondents
Regulatory/section requirements
Responses
per
respondent
Total annual
responses
Hours per
response
Total hour
burden
57.210(b)(1)(iii), Notification of Repayment ..................
57.210(b)(1)(iv), Notification During Deferment ...........
57.210(b)(1)(vi), Notification of Delinquent Accounts ...
57.210(b)(1)(x), Credit Bureau Notification ..................
57.210(b)(4)(i), Write-off of Uncollectible Loans ..........
57.211(a) Disability Cancellation ..................................
57.215(a)(2), Administrative Hearings ..........................
57.215(a)(d), Administrative Hearings ..........................
334
334
334
334
5
3
0
0
862.5
17.0
172.5
6
1
1
0
0
288,075
5,678
57,615
2,004
5
3
0
0
0.38
0.63
1.25
0.50
3.00
1.00
0
0
108,028
3,549
72,019
1,002
15
3
0
0
HPSL Subtotal .......................................................
........................
........................
........................
........................
306,029
NSL Program:
57.306(a)(2), Student Financial Aid Transcript ............
57.310(b)(1)(i), Entrance Interview ...............................
57.310(b)(1)(ii), Exit Interview ......................................
57.301(b)(1)(iii), Notification of Repayment ..................
57.310(b)(1)(iv), Notification During Deferment ...........
57.310(b)(1)(vi), Notification of Delinquent Accounts ...
57.310(b)(1)(x), Credit Bureau Notification ..................
57.310(b)(4)(i), Write-off of Uncollectible Loans ..........
57.311(a), Disability Cancellation .................................
57.315(a)(1)(ii), Administrative Hearings ......................
57.316(a)(d), Administrative Hearings ..........................
........................
282
348
348
348
348
348
23
16
0
0
........................
17.5
9.0
9.0
1.5
42.5
709.0
1.0
1.0
0
0
........................
4,935
3,132
3,132
522
14,790
246,732
23
16
0
0
........................
0.42
0.42
0.27
0.29
0.04
0.00
3.00
1.00
0
0
........................
2,048
1,300
830
151
592
86
69
16
0
0
NSL Subtotal .........................................................
........................
........................
........................
........................
5,092
*Includes active and closing schools.
Jackie Painter,
Acting Director, Division of Policy and
Information Coordination.
[FR Doc. 2014–28555 Filed 12–4–14; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
wreier-aviles on DSK5TPTVN1PROD with NOTICES
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel;
Outstanding Investigator Award 2.
Date: March 24–26, 2015.
Time: 6:00 p.m. to 5:00 p.m.
VerDate Sep<11>2014
15:07 Dec 04, 2014
Jkt 235001
Agenda: To review and evaluate grant
applications.
Place: Gaithersburg Marriott
Washingtonian Center, 9751 Washingtonian
Boulevard, Gaithersburg, MD 20878.
Contact Person: Peter J. Wirth, Ph.D.,
Scientific Review Officer, Research Programs
Review Branch, Division of Extramural
Activities, National Cancer Institute, 9609
Medical Center Drive, Room 7W154,
Rockville, MD 20850, 240–276–6434, pw2q@
nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel;
Outstanding Investigator Award 1.
Date: March 24–26, 2015.
Time: 6:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Gaithersburg Marriott
Washingtonian Center, 9751 Washingtonian
Boulevard, Gaithersburg, MD 20878.
Contact Person: Michael B. Small, Ph.D.,
Chief, Program and Review Extramural Staff
Training Office, Division of Extramural
Activities, National Cancer Institute, 9609
Medical Center Drive, Room 7W412,
Rockville, MD 20850, 240–276–6438,
smallm@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel;
Outstanding Investigator Award 3.
Date: March 24–26, 2015.
Time: 6:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Gaithersburg Marriott
Washingtonian Center, 9751 Washingtonian
Boulevard, Gaithersburg, MD 20878.
Contact Person: Shamala K. Srinivas,
Ph.D., Scientific Review Officer, Office of
PO 00000
Frm 00027
Fmt 4703
Sfmt 4703
Referral, Review, and Program Coordination,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, 7W530, Rockville, MD 20850, 240–
276–6442, ss537t@mail.nih.gov.
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/sep/sep.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: December 1, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–28530 Filed 12–4–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Human Genome Research
Institute; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
E:\FR\FM\05DEN1.SGM
05DEN1
]]>Agencies
[Federal Register Volume 79, Number 234 (Friday, December 5, 2014)]
[Notices]
[Pages 72188-72190]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-28555]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Agency Information Collection Activities: Submission to OMB for
Review and Approval; Public Comment Request
AGENCY: Health Resources and Services Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with Section 3507(a)(1)(D) of the Paperwork
[[Page 72189]]
Reduction Act of 1995, the Health Resources and Services Administration
(HRSA) has submitted an Information Collection Request (ICR) to the
Office of Management and Budget (OMB) for review and approval. Comments
submitted during the first public review of this ICR will be provided
to OMB. OMB will accept further comments from the public during the
review and approval period.
DATES: Comments on this ICR should be received no later than January 5,
2015.
ADDRESSES: Submit your comments, including the Information Collection
Request Title, to the desk officer for HRSA, either by email to
OIRA_submission@omb.eop.gov or by fax to 202-395-5806.
FOR FURTHER INFORMATION CONTACT: To request a copy of the clearance
requests submitted to OMB for review, email the HRSA Information
Collection Clearance Officer at paperwork@hrsa.gov or call (301) 443-
1984.
SUPPLEMENTARY INFORMATION:
Information Collection Request Title: Health Professions Student
Loan (HPSL) Program and Nursing Student Loan (NSL) Program
Administrative Requirements (Regulations and Policy).
OMB No. 0915-0047--Extension.
Abstract: The statutory authorities for the Health Professions
Student Loan (HPSL) Program, as authorized by Public Health Service
(PHS) Act sections 721-722, and 725-735, and the Nursing Student Loan
(NSL) Program, as authorized by PHS Act sections 835-842, contain a
number of recordkeeping and reporting requirements for academic
institutions and loan applicants. The applicable regulations for these
programs under 42 CFR part 57 details the various requirements (see
chart below).
Need and Proposed Use of the Information: The requirements are
essential for assuring that borrowers are aware of their rights and
responsibilities, academic institutions have accurate records of the
history and status of each loan account in order to pursue aggressive
collection efforts to reduce default rates, and that academic
institutions maintain adequate records for audit and assessment
purposes to help the U.S. Department of Health and Human Services
safeguard federal funds made through the Federal Capital Contribution
(FCC). Academic institutions are free to use improved information
technology to manage the information required by the regulations.
Likely Respondents: Financial Aid Directors working at institutions
participating in the HPSL and NSL Programs.
Burden Statement: Burden in this context means the time expended by
persons to generate, maintain, retain, disclose or provide the
information requested. This includes the time needed to review
instructions; to develop, acquire, install and utilize technology and
systems for the purpose of collecting, validating and verifying
information, processing and maintaining information, and disclosing and
providing information; to train personnel and to be able to respond to
a collection of information; to search data sources; to complete and
review the collection of information; and to transmit or otherwise
disclose the information. The total annual burden hours estimated for
this ICR are summarized in the table below.
Total Estimated Annualized Burden--Hours
Recordkeeping Requirements
----------------------------------------------------------------------------------------------------------------
Number of Total burden
Regulatory/section requirements record keepers Hours per year hours
----------------------------------------------------------------------------------------------------------------
HPSL Program:
57.206(b)(2), Documentation of Cost of Attendance........... 50 325 16,250
57.208(a), Promissory Note.................................. 90 325 29,250
57.210((b)(1)(i), Documentation of Entrance Interview....... 40 325 13,000
57.210(b)(1)(ii), Documentation of Exit Interview........... 80 334 26,720
57.215(a)&(d), Program Records.............................. 140 334 46,760
57.215(b), Student Records.................................. 70 334 23,380
57.215(c), Repayment Records................................ 150 334 50,100
-----------------------------------------------
HPSL Subtotal........................................... .............. .............. 205,460
-----------------------------------------------
NSL Program:
57.306(b)(2)(ii), Documentation of Cost of Attendance....... 16.0 282 4,512
57.308(a), Promissory Note.................................. 4.5 282 1,269
57.310(b)(1)(i), Documentation of Entrance Interview........ 1.5 282 423
57.310(b)(1)(ii), Documentation of Exit Interview........... 1.5 348 522
57.315(a)(1)&(a)(4), Program Records........................ 21.0 348 7,308
57.315(a)(2), Student Records............................... 8.5 348 2,958
57.315(a)(3), Repayment Records............................. 5.0 348 1,740
-----------------------------------------------
NSL Subtotal............................................ .............. .............. 18,732
----------------------------------------------------------------------------------------------------------------
* Includes active and closing schools.
HPSL data includes active and closing Loans for Disadvantaged Students (LDS) program schools.
Reporting Requirements
----------------------------------------------------------------------------------------------------------------
Number of Responses per Total annual Hours per Total hour
Regulatory/section requirements respondents respondent responses response burden
----------------------------------------------------------------------------------------------------------------
HPSL Program:
57.206(a)(2), Student n/a .............. .............. .............. ..............
Financial Aid Transcript...
57.208(c), Loan Information 325 299.5 97,338 0.63 60,836
Disclosure.................
57.210(b)(1)(i), Entrance 325 139.5 45,338 0.50 22,669
Interview..................
57.210(b)(1)(ii), Exit 334 113.5 37,909 1.00 37,909
Interview..................
[[Page 72190]]
57.210(b)(1)(iii), 334 862.5 288,075 0.38 108,028
Notification of Repayment..
57.210(b)(1)(iv), 334 17.0 5,678 0.63 3,549
Notification During
Deferment..................
57.210(b)(1)(vi), 334 172.5 57,615 1.25 72,019
Notification of Delinquent
Accounts...................
57.210(b)(1)(x), Credit 334 6 2,004 0.50 1,002
Bureau Notification........
57.210(b)(4)(i), Write-off 5 1 5 3.00 15
of Uncollectible Loans.....
57.211(a) Disability 3 1 3 1.00 3
Cancellation...............
57.215(a)(2), Administrative 0 0 0 0 0
Hearings...................
57.215(a)(d), Administrative 0 0 0 0 0
Hearings...................
-------------------------------------------------------------------------------
HPSL Subtotal........... .............. .............. .............. .............. 306,029
-------------------------------------------------------------------------------
NSL Program:
57.306(a)(2), Student .............. .............. .............. .............. ..............
Financial Aid Transcript...
57.310(b)(1)(i), Entrance 282 17.5 4,935 0.42 2,048
Interview..................
57.310(b)(1)(ii), Exit 348 9.0 3,132 0.42 1,300
Interview..................
57.301(b)(1)(iii), 348 9.0 3,132 0.27 830
Notification of Repayment..
57.310(b)(1)(iv), 348 1.5 522 0.29 151
Notification During
Deferment..................
57.310(b)(1)(vi), 348 42.5 14,790 0.04 592
Notification of Delinquent
Accounts...................
57.310(b)(1)(x), Credit 348 709.0 246,732 0.00 86
Bureau Notification........
57.310(b)(4)(i), Write-off 23 1.0 23 3.00 69
of Uncollectible Loans.....
57.311(a), Disability 16 1.0 16 1.00 16
Cancellation...............
57.315(a)(1)(ii), 0 0 0 0 0
Administrative Hearings....
57.316(a)(d), Administrative 0 0 0 0 0
Hearings...................
-------------------------------------------------------------------------------
NSL Subtotal............ .............. .............. .............. .............. 5,092
----------------------------------------------------------------------------------------------------------------
*Includes active and closing schools.
Jackie Painter,
Acting Director, Division of Policy and Information Coordination.
[FR Doc. 2014-28555 Filed 12-4-14; 8:45 am]
BILLING CODE 4165-15-P
